Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

被引:0
作者
He, Yan-Fei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hlth Management Ctr, 6 Fucheng Rd, Beijing 100048, Peoples R China
关键词
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy; PORTAL-VEIN LIGATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; SORAFENIB; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; EFFICACY; PLUS;
D O I
10.4251/wjgo.v16.i10.4289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, the World Journal of Gastrointestinal Oncology published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
引用
收藏
页码:4289 / 4297
页数:10
相关论文
共 50 条
[31]   Chemotherapy and target therapy for hepatocellular carcinoma:New advances and challenges [J].
Gan-Lu Deng ;
Shan Zeng ;
Hong Shen .
World Journal of Hepatology, 2015, 7 (05) :787-798
[32]   Molecular Targeted Therapy in Hepatocellular Carcinoma: Present Achievements and Future Challenges [J].
Giacomin, Anna ;
Sergio, Adriana ;
Vanin, Veronica ;
Gazzola, Alessia ;
Cazzagon, Nora ;
Farinati, Fabio .
DIGESTIVE DISEASES, 2012, 30 (03) :284-288
[33]   Lenvatinib as a therapy for unresectable hepatocellular carcinoma [J].
Spallanzani, Andrea ;
Orsi, Giulia ;
Andrikou, Kalliopi ;
Gelsomino, Fabio ;
Rimini, Margherita ;
Riggi, Laura ;
Cascinu, Stefano .
EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) :1069-1076
[34]   Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new? [J].
Zhang, Ze-Feng ;
Luo, Yu-Jun ;
Lu, Quan ;
Dai, Shi-Xue ;
Sha, Wei-Hong .
WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (09) :259-273
[35]   Resection of unresectable hepatocellular carcinoma after conversion therapy with apatinib and camrelizumab: a case report and literature review [J].
Liu, Xin-Liang ;
Li, Xiang-Ze ;
Chu, Yi-Fu ;
Liu, Feng ;
Tian, Hu .
FRONTIERS IN ONCOLOGY, 2024, 14
[36]   A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma [J].
Gan, Leijuan ;
Lang, Mengran ;
Tian, Xindi ;
Ren, Shaohua ;
Li, Guangtao ;
Liu, Yayue ;
Han, Ruyu ;
Zhu, Kangwei ;
Li, Huikai ;
Wu, Qiang ;
Cui, Yunlong ;
Zhang, Wei ;
Fang, Feng ;
Li, Qiang ;
Song, Tianqiang .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 :673-686
[37]   Systemic treatment for unresectable hepatocellular carcinoma [J].
Leowattana, Wattana ;
Leowattana, Tawithep ;
Leowattana, PathompThep .
WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (10) :1551-+
[38]   From Conversion to Resection for Unresectable Hepatocellular Carcinoma: A Review of the Latest Strategies [J].
Liang, Chen ;
He, Zhaoqian ;
Tao, Qiang ;
Tang, Xiang ;
Jiang, Lingmin ;
Tu, Xinyue ;
Liu, Zonghao ;
Chen, Hua ;
Xie, Feihu ;
Zheng, Yun .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
[39]   Pathological complete response after conversion therapy in unresectable hepatocellular carcinoma: a retrospective study [J].
Jia, Junjun ;
Ding, Chenyuan ;
Mao, Mengjie ;
Gao, Feng ;
Shao, Zhou ;
Zhang, Min ;
Zheng, Shusen .
BMC GASTROENTEROLOGY, 2024, 24 (01)
[40]   Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy? [J].
Jiang, Chao ;
Sun, Xiao-Dong ;
Qiu, Wei ;
Chen, Yu-Guo ;
Sun, Da-Wei ;
Lv, Guo-Yue .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (01) :7-13